Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria

Background: Atrial fibrillation (AF) is a chronic sustained heart rhythm disorder associated with an increased risk of stroke. Apixaban, a new oral anticoagulant, was approved by the European Medicines Agency for prevention of stroke in patients with AF. The efficacy of apixaban has been investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoudia, Yazid, Kongnakorn, Thitima, Merinopoulou, Evie, Bettayeb, Mohamed Said, Kherraf, Sid Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2017
Materias:
Cardiovascular Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471424/
https://www.ncbi.nlm.nih.gov/pubmed/37664691
http://dx.doi.org/10.36469/9797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471424/
https://www.ncbi.nlm.nih.gov/pubmed/37664691
http://dx.doi.org/10.36469/9797

Ejemplares similares